Tang M - Search Results

1

Harnessing Real-World Evidence to Advance Cancer Research.

Tang M, Pearson SA, Simes RJ, Chua BH. Tang M, et al. Curr Oncol. 2023 Feb 2;30(2):1844-1859. doi: 10.3390/curroncol30020143. Curr Oncol. 2023. PMID: 36826104 Free PMC article. Review.

2

Embracing the full spectrum of real-world data for cancer medicines research in Australia.

Tang M, Schaffer A, Pearson SA. Tang M, et al. Asia Pac J Clin Oncol. 2019 Jun;15(3):186-187. doi: 10.1111/ajco.13121. Epub 2019 Feb 12. Asia Pac J Clin Oncol. 2019. PMID: 30747483 No abstract available.

3

Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.

Tervonen HE, Daniels B, Tang M, Preen DB, Pearson SA. Tervonen HE, et al. Among authors: tang m. Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):812-820. doi: 10.1002/pds.4751. Epub 2019 Mar 12. Pharmacoepidemiol Drug Saf. 2019. PMID: 30861596

4

Challenges of international oncology trial collaboration-a call to action.

Tang M, Joensuu H, Simes RJ, Price TJ, Yip S, Hague W, Sjoquist KM, Zalcberg J. Tang M, et al. Br J Cancer. 2019 Oct;121(7):515-521. doi: 10.1038/s41416-019-0532-4. Epub 2019 Aug 5. Br J Cancer. 2019. PMID: 31378784 Free PMC article. Review.

5

Trastuzumab use in older patients with HER2-positive metastatic breast cancer: outcomes and treatment patterns in a whole-of-population Australian cohort (2003-2015).

Daniels B, Kiely BE, Tang M, Tervonen H, Pearson SA. Daniels B, et al. Among authors: tang m. BMC Cancer. 2019 Sep 11;19(1):909. doi: 10.1186/s12885-019-6126-y. BMC Cancer. 2019. PMID: 31510955 Free PMC article.

6

Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016).

Tang M, Schaffer A, Kiely BE, Daniels B, Simes RJ, Lee CK, Pearson SA. Tang M, et al. Br J Cancer. 2019 Nov;121(11):904-911. doi: 10.1038/s41416-019-0612-5. Epub 2019 Nov 1. Br J Cancer. 2019. PMID: 31673103 Free PMC article.

7

Evaluation of Phase II Trial Design in Advanced Pancreatic Cancer.

Tang M, Chen J, Goldstein D, Links M, Lord S, Marschner I, Simes RJ, Lee CK. Tang M, et al. Pancreas. 2019 Nov/Dec;48(10):1274-1284. doi: 10.1097/MPA.0000000000001429. Pancreas. 2019. PMID: 31688590

8

Correction: Treatment patterns and survival in HER2-positive early breast cancer: a whole-of-population Australian cohort study (2007-2016).

Tang M, Schaffer A, Kiely BE, Daniels B, Simes RJ, Lee CK, Pearson SA. Tang M, et al. Br J Cancer. 2020 Sep;123(5):868. doi: 10.1038/s41416-020-0908-5. Br J Cancer. 2020. PMID: 32472094 Free PMC article.

9

Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously.

Favell DL, Tang M, Daniels B, Vajdic CM, Zoega H, Pearson SA. Favell DL, et al. Among authors: tang m. Public Health Res Pract. 2020 Jun 30;30(2):3022013. doi: 10.17061/phrp3022013. Public Health Res Pract. 2020. PMID: 32601659 Free article. No abstract available.

10

Real-world data to advance HER2-targeted cancer medicines research: Playing to the strengths of clinical registry and administrative data.

Tang M, Daniels B, Schaffer AL, Pearson SA. Tang M, et al. Asia Pac J Clin Oncol. 2021 Aug;17(4):414-415. doi: 10.1111/ajco.13554. Epub 2021 Feb 19. Asia Pac J Clin Oncol. 2021. PMID: 33608985 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,932 results

Search Page

Filters